Search research articles
Contact Us
Filters
Showing results (31-40 of 170) with videos related to
Page
of 17
Sort By:
Therapeutic Advances in Medical Oncology
|
November 1, 2021
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Anne-Laure Giraudet, David Kryza, Michael Hofman, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia
Gavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Frontiers in Oncology
|
September 5, 2022
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
Ciara Conduit, Wei Hong, Felicity Martin, et al.
Nature Reviews. Urology
|
March 7, 2023
Treatment de-escalation for stage II seminoma
Georgina E Wood, Florence Chamberlain, Ben Tran, et al.
Urologic Oncology
|
November 21, 2022
Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis
Niranjan J Sathianathen, Henry Y C Pan, Nathan Lawrentschuk, et al.
Clinical Genitourinary Cancer
|
February 24, 2024
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT)
Lara Pemberton, Connor Allen, Eleanor Handel, et al.
Journal of Geriatric Oncology
|
September 30, 2025
Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies
Adel Shahnam, Nadia Hitchen, Sathya Manoharan, et al.
Analytical Chemistry
|
July 17, 2012
Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody
Taylor Zhang, Jennifer Zhang, Daniel Hewitt, et al.
Targeted Oncology
|
September 5, 2022
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm
Sophie O'Haire, Koen Degeling, Fanny Franchini, et al.
Trials
|
February 7, 2023
"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians
Khic-Houy Prang, Bill Karanatsios, Angela Zhang, et al.
Page
of 17
Search research articles
Search
Showing results (31-40 of 170) with videos related to
Sort By:
Page
of 17
Therapeutic Advances in Medical Oncology
|
November 1, 2021
PSMA targeting in metastatic castration-resistant prostate cancer: where are we and where are we going?
Anne-Laure Giraudet, David Kryza, Michael Hofman, et al.
Asia-Pacific Journal of Clinical Oncology
|
April 19, 2024
A practical guide for the use of apalutamide for non-metastatic castration-resistant prostate cancer in Australia
Gavin Marx, Simon Chowdhury, Laurence Krieger, et al.
Frontiers in Oncology
|
September 5, 2022
A meta-analysis of clinicopathologic features that predict necrosis or fibrosis at post-chemotherapy retroperitoneal lymph node dissection in individuals receiving treatment for non-seminoma germ cell tumours
Ciara Conduit, Wei Hong, Felicity Martin, et al.
Nature Reviews. Urology
|
March 7, 2023
Treatment de-escalation for stage II seminoma
Georgina E Wood, Florence Chamberlain, Ben Tran, et al.
Urologic Oncology
|
November 21, 2022
Emergence of triplet therapy for metastatic castration-sensitive prostate cancer: An updated systematic review and network meta-analysis
Niranjan J Sathianathen, Henry Y C Pan, Nathan Lawrentschuk, et al.
Clinical Genitourinary Cancer
|
February 24, 2024
Carboplatin in Metastatic Castrate Resistant Prostate Cancer: A Retrospective Study of Heavily Pretreated Patients (COMPACT)
Lara Pemberton, Connor Allen, Eleanor Handel, et al.
Journal of Geriatric Oncology
|
September 30, 2025
Impact of age and comorbidity on safety outcomes in phase 1 trial participants for metastatic solid malignancies
Adel Shahnam, Nadia Hitchen, Sathya Manoharan, et al.
Analytical Chemistry
|
July 17, 2012
Identification and characterization of buried unpaired cysteines in a recombinant monoclonal IgG1 antibody
Taylor Zhang, Jennifer Zhang, Daniel Hewitt, et al.
Targeted Oncology
|
September 5, 2022
Comparing Survival Outcomes for Advanced Cancer Patients Who Received Complex Genomic Profiling Using a Synthetic Control Arm
Sophie O'Haire, Koen Degeling, Fanny Franchini, et al.
Trials
|
February 7, 2023
"Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians
Khic-Houy Prang, Bill Karanatsios, Angela Zhang, et al.
Page
of 17